Kineret Effective As Early First-Line Treatment for Systemic JIA, 5-Year Follow-up Study Shows
News
Kineret (anakinra) is able to rapidly halt disease activity and sustain long-term remission as an initial single treatment for patients with systemic juvenile idiopathic arthritis (sJIA), a five-year follow-up study says. ... Read more